These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21463756)

  • 1. Biochemical and hematologic changes after percutaneous radiofrequency ablation of liver tumors: experience in 83 procedures.
    Cizginer S; Tatli S; Hurwitz S; Tuncali K; vanSonnenberg E; Silverman SG
    J Vasc Interv Radiol; 2011 Apr; 22(4):471-8. PubMed ID: 21463756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.
    Kao WY; Chiou YY; Hung HH; Chou YH; Su CW; Wu JC; Huo TI; Huang YH; Lin HC; Lee SD
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):528-36. PubMed ID: 21537128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
    Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures.
    Nair RT; Silverman SG; Tuncali K; Obuchowski NA; vanSonnenberg E; Shankar S
    Radiology; 2008 Jul; 248(1):303-11. PubMed ID: 18566180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evaluation of enzymatic and biochemical changes in radiofrequency liver resections].
    Finta O; Mocan L; Vlad L
    Chirurgia (Bucur); 2010; 105(4):493-9. PubMed ID: 20941971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bimodal electric tissue ablation-long term studies of morbidity and pathological change.
    Dobbins C; Brennan C; Wemyss-Holden S; Cockburn J; Maddern G
    J Surg Res; 2008 Aug; 148(2):251-9. PubMed ID: 18395751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of myocardial damage after radiofrequency ablation.
    Bednarek J; Tomala I; Majewski J; Szczepkowski J; Lelakowski J
    Kardiol Pol; 2004 Apr; 60(4):335-41. PubMed ID: 15226782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
    Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
    J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma.
    van Vledder MG; van Aalten SM; Terkivatan T; de Man RA; Leertouwer T; Ijzermans JN
    J Vasc Interv Radiol; 2011 Jun; 22(6):787-93. PubMed ID: 21616431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of neuroendocrine liver metastases.
    Elvin A; Skogseid B; Hellman P
    Abdom Imaging; 2005; 30(4):427-34. PubMed ID: 15791486
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver function tests in adults with Plasmodium falciparum infection.
    Davies MP; Brook GM; Weir WR; Bannister B; Tibbs C
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):873-5. PubMed ID: 8889453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation for the management of liver tumors.
    Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related acute hepatic enzyme elevation: a new disease entity?
    Nachnani JS; Hamid F; Pandya P; Clarkston W; Alba LM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):378. PubMed ID: 20134262
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.